NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Reuters
BY RANSDELL PIERSON
NEW YORK Wed Feb 26, 2014 1:00am EST

Dr. Vivek Subbiah, an oncologist at M.D. Anderson Cancer Center in Houston who is leading the DCVax-Direct trials, said he may present initial data at the annual meeting of the American Society of Clinical Oncology that begins May 30.

Subbiah and his colleagues test scores of experimental cancer drugs, many having new mechanisms of action.

"This is not a 'me-too' trial," Subbiah said. "It is one of the interesting technologies. Twenty years ago it was chemo, 10 years ago it was targeted therapies, and for this decade it will be drugs that boost the immune system."